Search

everythinglearnresearchcommunity

for

Search:↓

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Normal human melanocytes can avoid cell death through multiple pathways.

Human placenta hydrolysate reduces inflammatory pain and nerve damage in mice.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Triple therapy with clobetasol, hydroxychloroquine, and N-acetylcysteine is recommended for better outcomes in treating lichen planopilaris.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

New molecules can prevent cell death in hair follicles.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib significantly improved skin and hair conditions without side effects.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Platelet-rich plasma can help heal difficult gastrointestinal fistulas after surgery.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Krill oil may help reduce prostate enlargement and growth.